Cargando…
Targeting Platelets for the Treatment of Cancer
The majority of cancer-associated mortality results from the ability of tumour cells to metastasise leading to multifunctional organ failure and death. Disseminated tumour cells in the blood circulation are faced with major challenges such as rheological shear stresses and cell-mediated cytotoxicity...
Autores principales: | Elaskalani, Omar, Berndt, Michael C., Falasca, Marco, Metharom, Pat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532630/ https://www.ncbi.nlm.nih.gov/pubmed/28737696 http://dx.doi.org/10.3390/cancers9070094 |
Ejemplares similares
-
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance
por: Elaskalani, Omar, et al.
Publicado: (2017) -
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017) -
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
por: Elaskalani, Omar, et al.
Publicado: (2020) -
Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones
por: Elaskalani, Omar, et al.
Publicado: (2018) -
The History of Armand Trousseau and Cancer-Associated Thrombosis
por: Metharom, Pat, et al.
Publicado: (2019)